Astrazeneca (AZN) Operating Leases (2019 - 2026)
Astrazeneca (AZN) posted quarterly Operating Leases of $2.3 billion for Q2 2026, up 82.55% year-over-year from $1.3 billion in Q2 2025, and up 254.29% quarter-over-quarter from -$1.5 billion in Q1 2026.
Astrazeneca (AZN) Operating Leases (2019 - 2026) Analysis & Trends
Astrazeneca's Operating Leases history runs 8 years deep, the most recent figure standing at $2.3 billion for Q2 2026.
- In Q2 2026, Operating Leases rose 82.55% year-over-year to $2.3 billion; the TTM figure through Jun 2026 stood at $2.3 billion (up 82.55% YoY), while the FY2025 annual figure was $1.4 billion, down 2.13% from the prior year.
- Operating Leases for Q2 2026 stood at $2.3 billion, up from -$1.5 billion in the prior quarter.
- The five-year high for Operating Leases was $2.3 billion in Q2 2026, with the low at -$1.5 billion in Q1 2026.
- The 5-year median for Operating Leases is -$723.0 million (2022), against an average of -$156.7 million.
- The sharpest annual moves came in 2022 and 2025: Operating Leases sank 97.49% in 2022, then soared 234.04% in 2025.
- Astrazeneca's Operating Leases stood at $953.0 million in 2022, then gained by 18.36% to $1.1 billion in 2023, then advanced by 28.72% to $1.5 billion in 2024, then slipped by 2.13% to $1.4 billion in 2025, then jumped by 63.41% to $2.3 billion in 2026.
- Business Quant data shows AZN's Operating Leases at $2.3 billion in Q2 2026, -$1.5 billion in Q1 2026, and $1.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.59 Bn | 632.83 Bn | 17.26 Bn |
| 2 | AbbVie | 470.48 Bn | 463.91 Bn | 12.70 Bn |
| 3 | Merck | 375.12 Bn | 367.98 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.96 Bn | 295.27 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.26 Bn | 252.36 Bn | 12.86 Bn |
| 6 | Amgen | 237.14 Bn | 223.15 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.99 Bn | 179.82 Bn | 6.22 Bn |
| 8 | Pfizer | 160.23 Bn | 148.53 Bn | 10.94 Bn |
| 9 | Gsk | 106.11 Bn | 101.94 Bn | 8.24 Bn |
| 10 | Sanofi | 55.21 Bn | 47.83 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.32 Bn |
| Mar 31, 2026 | -1.51 Bn |
| Dec 31, 2025 | 1.42 Bn |
| Sep 30, 2025 | -1.38 Bn |
| Jun 30, 2025 | 1.27 Bn |
| Mar 31, 2025 | -1.20 Bn |
| Dec 31, 2024 | 1.45 Bn |
| Sep 30, 2024 | -1.11 Bn |
| Jun 30, 2024 | -949.00 Mn |
| Mar 31, 2024 | -961.00 Mn |
| Dec 31, 2023 | 1.13 Bn |
| Sep 30, 2023 | -744.00 Mn |
| Jun 30, 2023 | -722.00 Mn |
| Mar 31, 2023 | -730.00 Mn |
| Dec 31, 2022 | 953.00 Mn |
| Sep 30, 2022 | -668.00 Mn |
| Jun 30, 2022 | -685.00 Mn |
| Mar 31, 2022 | -724.00 Mn |
| Dec 31, 2021 | 987.00 Mn |
| Sep 30, 2021 | -733.00 Mn |